E-DRUG: October 16 Washington: Do US FTAs limit access to medicines?
---------------------------------------------------
An event takes place on October 16 in Washington D.C. with Prof. Jiraporn Limpananont from Thailand about the impact of US trade agreements on access to medicines and public health.
Do U.S. Free Trade Agreements Limit Access to Medicines?
Exploring the Impact of the Proposed U.S.-Thailand Free Trade Agreement on
Availability of Generic HIV/AIDS Drugs
Featuring
Jiraporn Limpananont
Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok
With discussants
Mead Over
Senior Fellow, Center for Global Development
Author of The Economics of Effective AIDS Treatment: Evaluating Policy
Options for Thailand
and
Michael Ryan
Professor of Law, Georgetown University
Moderated by
Kimberly Elliott
Senior Fellow, Center for Global Development and Institute for International Economics
Monday, October 16th, 2006
1:00 p.m. 2:30 p.m.
at
Center for Global Development
1776 Massachusetts Avenue, NW, Third Floor, Washington, D.C.
Thailand and the United States began negotiating a free trade agreement in
2004. Although negotiations are now stalled, the latest version of the FTA
would restrict Thailand¹s ability to produce or import generic AIDS drugs.
Limpananont argues that these restrictions could have a significant impact
on Thailand¹s national HIV/AIDS treatment program. We anticipate a lively
discussion about the tradeoffs between the potential economic benefits of
FTAs and access to medicines.
Please RSVP to Events@CGDEV.ORG
Center for Global Development | 1776 Massachusetts Ave, NW | Third Floor |
Washington | DC | 20036
---------------------------
Best
Asia Russell
Health GAP (Global Access Project)
tel: +1 267 475 2645
asia@healthgap.org
http://www.healthgap.org